McCarthy Against IP Centralization

In response to calls to centralize all trademark appeals to the Federal Circuit, leading trademark expert – literally, the man who wrote the book on trademarks – J. Thomas McCarthy (and Dina Roumiantseva), think not.

With some regularity over the years, a proposal is made to change the Lanham Act so that appeals in all Lanham Act trademark and false advertising cases from district courts across the United States will be diverted from the regional circuit courts of appeal to the Court of Appeals for the Federal Circuit. We think it is time to discuss this proposal head on and hopefully to convince the reader that this diversion is not a good idea and should never be implemented. Advocates of this proposal claim that trademark law would benefit from the consistency that a single appeals court could provide and that the Federal Circuit has exceptional expertise in trademark law. We believe, however, that trademark law does not suffer from the kind of circuit conflict that led to the channeling of all patent appeals to the Federal Circuit in 1982. Moreover, our review of case law suggests that some regional circuits have a comparable or greater experience with trademark law. We argue that no change in the present system of trademark appeals is needed.

source

Posted in Uncategorized | Tagged | Leave a comment

USPTO to Open Satellite Office in Dallas

The U.S. Patent & Trademark Office is set to open a satellite office in Dallas, Texas on 9 November 2015.

The U.S. Patent and Trademark office, opening at the Terminal Annex Federal Building in Dallas on Nov. 9, is one of three regional offices established as a result of the Leahy-Smith America Invents Act signed into law by President Obama. The goal of the act was to improve personal interaction between the office and the nation’s innovation community.

source

Posted in Uncategorized | Leave a comment

Court Cancels URBAN HOMESTEADING Trademark

In a longstanding dispute between advocates of urban farming and the Dervaes family of Pasadena, a federal district judge gave opponents of the Dervaes’ a partial victory when he  ordered cancellation of the trademark for URBAN HOMESTEADING on the grounds that the mark is too generic a term to deserve protection.

The complaint was filed 2014 by Denver Urban Homesteading, a farmer’s market in Denver whose Facebook page was suspended after an infringement complaint filed by the ex-wife of Jules Dervaes.

The long, sordid history can be read here.

source

Posted in Uncategorized | Tagged , , , | Leave a comment

AstraZeneca Asserts Its Purple Rights

Nexium**Update here**

Global pharma giant AstraZeneca has asserted its rights to its purple trademark. AstraZeneca filed a complaint at the US District Court for the District of Delaware on 28 October, claiming Indian drug maker Dr. Reddy’s Laboratories’s generic version of Nexium (esomeprazole) breaches the trademark rights behind its branded drug.

AstraZeneca owns  trademark registrations for the color purple as applied to a capsule, the color purple applied to a capsule with both two and three gold rings, and a word mark for “The Purple Pill”.

According to AstraZeneca, Dr. Reddy’s introduced its purple Nexium generic “long after AstraZeneca’s trademarks became famous”.

Single color marks are notoriously difficult to register and protect. This should prove an interesting case to follow.

source

Posted in Uncategorized | Tagged , , , | 1 Comment

Ipsen & Telesta Reach Deal

Ipsen and Telesta Therapeutics Inc. announced yesterday that they have entered into an exclusive licensing agreement for Ipsen to develop and commercialize MCNA1 for the treatment of high risk non-muscle invasive bladder cancer (NMIBC) in all countries of the world, with the exception of the United States (because Telesta is establishing commercial operations there), Canada, South Africa, Mexico, South Korea and Japan.

The FDA has assigned priority review to Telesta’s BLA with a review (PDUFA) date of February 27, 2016. Telesta retains ownership of MCNA rights in the U.S. and Japan and will be responsible for the commercial launch of MCNA in the United States. By contrast, Ipsen will begin discussions with regulatory agencies to identify the appropriate review process and potential requirements for the product in Europe and other key licensed territories.

source

Posted in Pharmaceutical Trademarks, Pharmaceuticals | Leave a comment

Walmart Avoids Federal Action

Screen Shot 2015-10-22 at 14.30.11Walmart has successfully avoided action by the Federal Trade Commission (“FTC”) concerning Walmart’s mislabeling of products as  “Made in the U.S.A.,” when they were, in fact, not made in the U.S.A.

The retailer was forced to remove “Made in the USA” logos from its website after an inquiry by the Federal Trade Commission into its labeling practices.

In a letter dated October 20, 2015, the FTC confirmed that it would not pursue legal action against Walmart because, among other things, Walmart had taken voluntary steps to “prevent consumer deception,” including removing “Made in USA” logos from product listings on its website and removing U.S. country of origin claims that appeared in product descriptions or titles. Also, in some cases, Walmart is also making more detailed disclosures regarding the percentage of U.S. content contained in the products.

Walmart’s conduct was particularly troubling because, two years ago, Walmart announced a plan to source an additional $250 billion worth of U.S-made goods over the following decade, part of a campaign to improve its reputation as a corporate citizen.

source

Posted in Uncategorized | Tagged , , , | Leave a comment

Ninth Circuit Does About-Face

In its second appellate review of the same case, the Ninth Circuit has done an about-face. In its second review of the case the US Court of Appeals for the Ninth Circuit set aside its own ruling that found Amazon could face trial over allegations that it confused users by displaying the watches of competitors when they searched for Multi Time Machine (MTM) products through its marketplace. Judge Barry Silverman, writing for the majority, ruled that Amazon was not liable for trademark infringement because “there is no likelihood of confusion in Amazon’s use of MTM’s trademarks” because Amazon’s “clear labeling of the products it carries by brand name and model, accompanied by a photograph of the item, no rational trier could find that a customer accustomed to shopping online would likely be confused.”

Even though MTM’s watches are not sold through the Amazon marketplace, a search for “MTM Special Ops” yields competitors’ watches in results. On this basis, MTM filed a lawsuit for trademark infringement.

Dissenting from the opinion, Judge Carlos Bea argued that the Ninth Circuit does not have the authority to address MTM’s argument that a consumer might be confused into thinking a relationship exists between MTM and a competitor.

The opinion may be accessed here.

source

Posted in Uncategorized | Leave a comment

Google Books is Fair Use, According to 2nd Circuit

Screen Shot 2015-10-22 at 14.03.51On October 16, 2015, the Second Circuit Court of Appeals confirmed that Google can digitally scan millions of books and make snippets of them available for searching. The Google Books service is a fair use under U.S. copyright law.

“Google’s making of a digital copy to provide a search function is a transformative use, which augments public knowledge by making available information about the plaintiffs’ books without providing the public with a substantial substitute for matter protected by the plaintiffs’ copyright interests in the original works or derivatives of them. The same is true, at least under present conditions, of Google’s provision of the snippet function.”

The case has been ongoing since 2005 when the Authors Guild took Google to court in 2005.

The opinion may be accessed here.

source

Posted in Uncategorized | Tagged , | Leave a comment

Antibiotic Pipeline Growing…

“After years of growing alarm, researchers are beginning to pick up the pace of developing new drugs to treat bacterial infections, according to a new viewpoint in ACS Infectious Diseases. Five new antibiotics that can treat drug-resistant infections were approved by the US Food and Drug Administration between May of 2014 and February 2015, and a new batch is on its way through the pipeline.”

source

Posted in Uncategorized | Leave a comment

Yelp Sues South Park Creators

Yelp, Inc. has sued “South Park” creators, Trey Parker and Matt Stone, and Comedy Central for damages caused by the latest episode of South Park which lampooned the customer review and local business rating website, entitled “You’re Not Yelping”. Yelp seeks $10 million in damages for libel and slander.

**Update** This is apparently a joke. Perhaps the real NBC should sue nbc.com.co… (link)

source

Posted in Uncategorized | Leave a comment